Skip to main content
Clinical Trials/NCT02555553
NCT02555553
Completed
Not Applicable

Noom Monitor for Binge Eating

Icahn School of Medicine at Mount Sinai1 site in 1 country225 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Binge Eating Disorder
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
225
Locations
1
Primary Endpoint
Objective Binge Days
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates the delivery of CBT-GSH by utilizing a patient interface that increases adherence and provides between-session reminders of CBT-GSH principles. In addition, the Noom Monitor includes a therapist interface with weekly feedback to the provider about patient progress. This application has several primary objectives, including: (1) testing the real-world effectiveness of the Noom Monitor in a clinical setting, and (2) establishing a database of training materials for Noom Monitor. The knowledge gained from the current study will contribute to our understanding of the role of new emerging mobile technologies in augmenting existing treatments.

Detailed Description

Binge eating is a core maladaptive behavior characteristic of several forms of eating pathology, including bulimia nervosa (BN) and binge eating disorder (BED). These chronic conditions affect approximately 5% of the population, and cause significant psychosocial and physical impairment. However, a number of barriers prevent the implementation of effective treatments, including poor treatment adherence, a paucity of specialized therapists, and high rates of drop out. The guided self-help version of cognitive-behavior therapy (CBT-GSH) is a brief 8-session highly scalable treatment to reduce binge eating. Moreover, CBT-GSH is a cost-effective empirically supported treatment that has been demonstrated to reduce total health care costs. Although CBT-GSH for BN and BED is effective, few individuals receive these treatments and the majority of other available treatments do not meet adequate standards for care for eating disorders. There are a number of reasons for why this is the case, but an important concern about CBT-GSH is participant burden. The primary CBT-GSH intervention is self-monitoring, a uniquely effective technique for reducing binge eating episodes; however, traditional self-monitoring is time-intensive and cumbersome because of its paper-and-pencil format. In addition, other behavioral strategies utilized in CBT-GSH (e.g., the development of regular eating) require a high degree of participant engagement outside of session. Novel technologies, such as those available with smartphones, offer potentially important means for reducing participant burden in the delivery of CBT-GSH. The purpose of the proposed is to test the primary efficacy of a novel mobile app, 'Noom Monitor' in a large population of binge eaters relative to a well-established treatment as usual (TAU) control condition. The investigative team developed these products via phase I study (R41-MH096435) to facilitate delivery of a cognitive-behavior therapy version of Guided Self-Help. The efficacy and product development aims of this proposal will be used to support the commercial launch of Noom Monitor, a smartphone platform.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
May 1, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Meets for DSM-5 BN or BED criteria
  • Between the ages of 18 and 55
  • Males and females
  • BMI greater than 18.5 and less than 40
  • Medical clearance in the case of reported purging or extreme exercise
  • Free of psychiatric medication for at least 2 weeks prior to study or on a stable dose of medication for 4 weeks
  • 1 year continuous enrollment in Kaiser Permanente Northwest health plan

Exclusion Criteria

  • Has undergone bariatric surgery
  • Demonstrates need for higher level of care (e.g., very low weight (\<18.5))
  • Current comorbid substance dependence, bipolar or psychotic illness
  • Current suicidal ideation
  • Previously received Enhance Cognitive behavioral therapy or Cognitive behavioral therapy-guided self help
  • Previously read Overcoming Binge Eating by Christopher Fairburn
  • Purging and/or laxative use more than 2x a day on average over the last month.

Outcomes

Primary Outcomes

Objective Binge Days

Time Frame: At 52 weeks

Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes

Sum of Compensatory Episodes

Time Frame: At 52 weeks

Sum of days where vomiting, laxative, or compulsive exercise occurs -sum of 3 items on EDE-Q v6

Secondary Outcomes

  • Shape Concern Subscale(At 52 weeks)
  • Clinical Impairment Assessment(At 52 weeks)
  • Dietary Restraint Subscale(At 52 weeks)
  • Personal Health Questionnaire(At 52 weeks)
  • Quality of Life Scale(At 52 weeks)
  • Eating Concern Subscale(At 52 weeks)
  • Global Eating Disorder Subscale(At 52 weeks)
  • Weight Concern Subscale(At 52 Weeks)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
An App Responding to Behaviour of People to Promote Mental Wellbeing in Anxious YouthAnxietySleep Problems
NCT06748833Dalhousie University101
Recruiting
Not Applicable
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and ViolenceHIV/AIDSMental Health Issue
NCT06458660Guiding Right, Inc.60
Completed
Not Applicable
FoodSteps for Binge Eating & Food InsecurityBinge EatingType 2 DiabetesFood Insecurity
NCT06348251Northwestern University31
Terminated
Not Applicable
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Lung Non-Small Cell CarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8
NCT04705025Jonsson Comprehensive Cancer Center5
Recruiting
Not Applicable
EMOTE: a Smartphone Application for Binge Eating Based on DBT SkillsBinge Eating
NCT06683456Universidade do Porto68